|
With Vaprisol, the water falls but the salt remains
Vaprisol is an IV therapy for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients. Vaprisol targets the neurohormone arginine vasopressin (AVP), the key regulator of salt and water balance, and raises serum sodium concentration through aquaresis—the electrolyte-sparing excretion of free water.1,2 Vaprisol Premixed in 5% Dextrose is conveniently packaged in single-use containers, so it’s ready to use right when you need it—no dilution or mixing necessary.
References: 1. Vaprisol Prescribing Information. Astellas Pharma US, Inc. 2. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471-503. 3. Douglas I. Hyponatremia: why it matters, how it presents, how we can manage it. Cleve Clin J Med. 2006;73(suppl 3):S4-S12. 4. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459-481.
Stay Informed
Register to receive additional information and important updates about Vaprisol.
Click Here
Vaprisol Provides
Proven Efficacy
Learn more about how Vaprisol raises serum [Na+] in a prompt but controlled fashion.
Click Here
|